Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TOFACITINIB
- Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica
- Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata
- Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
- Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis
- Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib
- ToFAcitinib in Early Active Axial SpondyloarThritis:
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Study of Tolerability, Safety, and Pharmacokinetics of ZL-82 in Healthy Adult Subjects.
- A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs
- Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
- Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis
- Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis
- Therapies for Down Syndrome Regression Disorder
- To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks
- Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis
- Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
- Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis
- Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Treatment of Idiopathic Inflammatory Myopathies
- Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma
- Tofacitinib in Recurrent GBM Patients
- Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
- Stand UP to Rheumatoid Arthritis (SUPRA)
- Role of Tofacitinib in Vitiligo Patients
- Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid
- Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.
- Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
- The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis
- Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis
- A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
- Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis
- Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome
- COVID-19 VaccinE Response in Rheumatology Patients
- Tofacitinib in Prevention of Photosensitivity in Lupus
- A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 3
- Effect of Tofacitinib in Treating ANCA-associated Vasculitis
- Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus
- The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients
- Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
- The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA
- The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis
- Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management
- Combination of Baricitinib and Adalimumab in Rheumatoid Arthritis
- GCs Sparing Regimen in PMR
- Tofacitinib for the Treatment of Refractory Immune-related Colitis From Checkpoint Inhibitor Therapy- TRICK Study
- Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia
- Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Tofacitinib For Treatment Of Chronic Pouchitis
- A Study of JNJ-64251330 in Healthy Participants
- Xeljanz and Healthy Diet
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome
- Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients
- Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia
- Tofacitinib Citrate Topical Gel 3.2% FDA BA Bridging Study
- Tofacitinib Versus Methotrexate as the First Line DMARD in the Treatment of Rheumatoid Arthritis
- Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study
- Tofacitinib for Treatment of Moderate COVID-19
- TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE
- Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy
- PK and Bioavailability Comparison of Tofacitinib Between a Modified Release and The Immediate Release Formulation
- TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia
- A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations
- TOFAcitinib in SARS-CoV2 Pneumonia
- Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease
- Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
- Tofacitinib for Immune Skin Conditions in Down Syndrome
- PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis
- Tofacitinib in Depression (TIDE)
- Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers
- A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants.
- Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
- Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
- Advanced Therapeutics in Rheumatoid Arthritis (RA)
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Dru
- Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
- Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers
- Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
- Examination of Efficacy and Safety of Baricitinib in RA Patients
- Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial
- Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis
- Effect of Baricitinib Treatment on Peripheral Bone in RA
- Tofacitinib Combined With Chidamide in R/R ENKTCL
- Tofacitinib for Inflammatory Eye Disease
- Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in Bangladesh
- Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)
- Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus
- A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission
- Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR Formulations
- TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
- Study of Tofacitinib in Refractory Dermatomyositis
- A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA
- Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate
- Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis
- Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
- Efficacy Study Of Tofacitinib In Pediatric JIA Population
- An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus
- A Study To Evaluate The Effect Of Food On The Behavior of Tofacitinib Modified Release 22 Milligram Tablets In Healthy Volunteers
- Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants
- Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
- A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis
- Tofacitnib for the Treatment of Alopecia Areata and Variants
- An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
- A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate
- Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
- A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese Volunteers
- Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)
- Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
- Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis
- Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
- Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
- Tofacitinib Ointment For Chronic Plaque Psoriasis
- Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
- A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494
- Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis
- A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers
- Tofacitinib Bioequivalence Study Comparing Tablets And Capsules
- Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
- Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
- A Phase 1 Study To Evaluate The Pharmacokinetics And Safety Of Three Modified Release And One Immediate Release Formulations Of Tofacitinib (CP-690,550) In Healthy Volunteers
- A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis
- A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
- A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
- Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients
- Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Clinical trials list
click for details